RecruitingNot ApplicableNCT03976999

Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers

Development of a Prospective and Monocentric Cinical and Biological Database in Epithelial Ovarian Cancer, Fallopian Tube Cancer and Primitive Peritoneal Cancer


Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle

Enrollment

300 participants

Start Date

Jul 5, 2017

Study Type

INTERVENTIONAL

Conditions

Summary

A Clinical and Biological Database will provide to the scientific community a collection of blood and tissues with clinical datas to improve knowledge about cancer and help to develope new cancer treatments. This database is specific to epithetial ovarian cancer, Fallopian tube cancer and Primitive peritoneal cancer.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study creates a database of clinical and biological data from patients newly diagnosed with ovarian, fallopian tube, or peritoneal cancer. The goal is to advance research and improve outcomes for these cancers. **You may be eligible if...** - You are 18 or older - You have recently been diagnosed with epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer - You are eligible for at least one surgery and chemotherapy - You have given written informed consent **You may NOT be eligible if...** - You are not enrolled in a social protection plan (in France) - You are pregnant or breastfeeding - You are under legal guardianship - Regular follow-up is not possible due to personal or logistical reasons Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBiological collection

* Blood samples collected at different times : Before treatment (T1) , after chemotherapy (T2), after interval surgery (T3) and after cancer reccurence (T4) * Tissue samples (tumor tissue and healthy tissue) collected during the surgery


Locations(1)

ICM - Institut régional du Cancer Montpellier

Montpellier, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03976999


Related Trials